Logo

Helius Medical's PoNS Receives the US FDA's Approval to Improve Gait in Multiple Sclerosis Patients

Share this

Helius Medical's PoNS Receives the US FDA's Approval to Improve Gait in Multiple Sclerosis Patients

Shots:

  • The approval is based on two clinical studies and a retrospective analysis of RWD. The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients aged ⥸22yrs.
  • The approval will help in improving the walking gait of people with MS in combination with a therapeutic program for exercise and balance
  • PoNS  is a neuromuscular tongue stimulator that consists of a non-implantable apparatus to generate electrical pulses for stimulation of the trigeminal and facial nerves via the tongue to provide treatment of motor deficits

­ | Ref: PRNewswire | Image: Helius

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions